Eden Biodesign is to invest $100m in expanding its Liverpool, UK, manufacturing facility. The company plans to recruit 35 additional staff to fulfil Watson’s five-year contract to develop a Follicle Stimulating Hormone.
Liverpool Daily Post
Thursday 25 November 2010
Eden to expand facility
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment